Shyld AI, a healthcare technology company pioneering Physical AI for hospital operations, will exhibit at the APIC 2026 Annual Conference, taking place June 15 through 17 at the Music City Center in Nashville. The event is expected to welcome more than 2,150 infection prevention professionals from across the globe.
Throughout the three-day conference, Shyld AI will demonstrate its action-based AI agents, which combine onboard sensors with autonomous UV-C disinfection and real-time workflow intelligence inside hospital rooms. The agents are powered by VERTEX, Shyld AI’s proprietary foundation model trained on real-world hospital environments.
In addition to autonomous disinfection, Shyld AI’s platform monitors OR traffic patterns, room entries and exits, delay causes, and missing supplies that can lead to avoidable foot traffic during procedures. The system also supports hand hygiene monitoring and can help identify potential sources of cross-contamination, including risks such as water splash in patient rooms and procedural areas.
The result is a new category of intelligence in infection control: AI agents that not only detect contamination and workflow risks, but also act on them in real time, without adding workload to clinical or environmental services teams.
Booth visitors will see live demonstrations of how Shyld AI agents detect cross-contamination events and deliver autonomous UV-C disinfection in seconds.
Healthcare-associated infections still contribute to roughly 72,000 deaths each year in the United States, according to CDC data, making infection prevention a growing priority for health systems nationwide. Shyld AI’s technology is currently deployed in more than 30 U.S. hospitals, and a peer-reviewed Stanford University study published in the American Journal of Infection Control found that the company’s system reduced cumulative microbial bioburden by more than 93 percent compared with a control room running standard manual disinfection protocols.
Shyld AI Founder and CEO Mohammad Noshad described the limitations of manual disinfection.
“With manual, there’s no way for you to monitor if these processes are being done properly. There’s a good chance that people are missing areas or the contact time of the chemicals is not enough,” he said.
At APIC 2026, Shyld AI will demonstrate how autonomous agents can help close those gaps. Throughout the exhibit hall, the company’s clinical and engineering teams will be available to walk health system leaders through deployment considerations and answer questions about workflow integration.
